Trademark: 85484000
Word
ALRIZDA
Status Date
Monday, February 25, 2013
Filing Date
Wednesday, November 30, 2011
Published for Opposition
Tuesday, May 29, 2012
Abandoned Date
Monday, February 25, 2013
5 Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of the symptoms of Alzheimer's disease, schizophrenia, residual phase schizophrenia, and attention deficits
Color is not claimed as a feature of the mark.
The mark consists of the word "Alrizda" underneath a partial sunburst design.
Feb 25, 2013
Abandonment Notice Mailed - No Use Statement Filed
Feb 25, 2013
Abandonment - No Use Statement Filed
Jul 24, 2012
Noa E-Mailed - Sou Required From Applicant
May 29, 2012
Official Gazette Publication Confirmation E-Mailed
May 29, 2012
Published For Opposition
May 9, 2012
Notification Of Notice Of Publication E-Mailed
Apr 21, 2012
Law Office Publication Review Completed
Apr 21, 2012
Assigned To Lie
Mar 29, 2012
Approved For Pub - Principal Register
Mar 20, 2012
Attorney Revoked And/Or Appointed
Mar 20, 2012
Teas Revoke/Appoint Attorney Received
Mar 27, 2012
Teas/Email Correspondence Entered
Mar 27, 2012
Correspondence Received In Law Office
Mar 27, 2012
Teas Response To Office Action Received
Feb 14, 2012
Notification Of Non-Final Action E-Mailed
Feb 14, 2012
Non-Final Action E-Mailed
Feb 14, 2012
Non-Final Action Written
Feb 7, 2012
Assigned To Examiner
Dec 7, 2011
Notice Of Design Search Code Mailed
Dec 6, 2011
New Application Office Supplied Data Entered In Tram
Dec 3, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
